Nutritional composition for enhancing mitochondria of micropterus salmoides by targeting PGC1beta gene as well as preparation method and application of nutritional composition

By targeting the PGC1β gene, the nutritional composition prepared with the combination of dandelion flavonoids, baicalin and citrustin was solved, and the problem of energy metabolism disorders and drug residues in aquaculture was significantly improved, which greatly improved the mitochondrial function and feed utilization of largemouth black bass It achieves efficient and safe breeding effects.

CN118901951APending Publication Date: 2024-11-08SOUTH CHINA AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411228749.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-03
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The high sugar and high fat feed used in existing aquaculture leads to disorders of energy metabolism in fish, and Western medicines are likely to lead to drug resistance and drug residues during use, and there is a lack of PGC1β gene-related products for aquatic animals.

Method used

By targeting the PGC1β gene, nutritional compositions that enhance the mitochondria of large mouth black bass are prepared by using the combination of dandelion flavonoids, baicalin and citrutin, as an efficient and environmentally friendly aquatic feed additive to enhance the energy metabolism function of fish.

Benefits of technology

It significantly improves the number and function of mitochondria in fish, improves feed utilization and economic benefits of breeding, avoids drug residues, and provides a safe and effective solution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118901951A_ABST
    Figure CN118901951A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of aquaculture, and discloses a nutritional composition for enhancing mitochondria of micropterus salmoides by targeting a PGC1beta gene as well as a preparation method and application of the nutritional composition, and the nutritional composition comprises the following components in parts by weight: 1-35 parts of dandelion flavone; 5 to 40 parts of baicalin; 5 to 35 parts of toosendanin; and 390 to 489 parts of expanded perlite. Different biological structures of the raw materials are fully utilized, scientific compatibility is carried out to play a synergistic role, the PGC1beta gene is targeted, the biosynthesis function of micropterus salmoides mitochondria is enhanced, the number and functions of mitochondria in fish bodies are increased, the energy metabolism capacity of the micropterus salmoides are improved, the utilization rate of feed is increased, and the micropterus salmoides feed can be applied to the field of micropterus salmoides culture.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of aquaculture, and in particular relates to a nutrient composition for enhancing mitochondria of largemouth bass by targeting PGC1β gene, and a preparation method and application thereof. Background Art

[0002] In order to reduce the cost of aquaculture, high-sugar and high-fat feeds are widely used, and the use of these feeds can cause energy metabolism disorders in fish, hinder fish growth, and even cause a large number of deaths. Studies have shown that the body's energy metabolism is closely related to the function and number of mitochondria in the body. Peroxisome proliferator-activated receptor γ coactivator 1β (PGC1β) belongs to the PGC1 transcription coactivator family. Its activation can enhance the biosynthesis function of mitochondria, thereby increasing the number and function of mitochondria in the body and improving the body's energy metabolism ability. At present, a variety of Western medicines have been developed for this gene to improve the body's mitochondrial function, but no products developed around this gene have been seen in fish. In addition, Western medicines are prone to drug resistance and drug residues in aquatic animals during use, which restricts their widespread use in feed. Dandelion flavonoids, baicalin, and toosendanin are all extracts of medicinal plants, and they have different biological structures. Studies on mammals have shown that all three have the function of regulating the body's metabolism. However, there is a lack of research on the effects of the three on the metabolic function of aquatic animals. There has been no report on any product that utilizes the different characteristics of the biological structures of the three substances to scientifically combine and exert synergistic effects to regulate the mitochondrial function of aquatic animals and improve metabolic capacity. Summary of the invention

[0003] In order to solve the above-mentioned deficiencies and shortcomings of the prior art, the purpose of the present invention is to provide a nutritional composition for enhancing the mitochondria of largemouth bass by targeting the PGC1β gene. The composition increases the expression of the PGC1β gene by targeting the PGC1β gene, thereby enhancing the biosynthetic capacity of mitochondria in largemouth bass and improving the energy metabolism function of the fish.

[0004] Another object of the present invention is to provide a method for preparing the above-mentioned nutritional composition for enhancing the mitochondria of largemouth bass. The method uses PGC1β as the target, and the pharmacological synergistic relationship between dandelion flavonoids, baicalin and toosendanin is used to prepare a nutritional composition for enhancing the mitochondrial function of largemouth bass.

[0005] Another object of the present invention is to provide the use of the above-mentioned nutritional composition for enhancing the mitochondria of largemouth bass by targeting the PGC1β gene. The composition can be used as a highly efficient and environmentally friendly aquatic feed additive to greatly reduce feed costs and improve the economic benefits of aquaculture.

[0006] The purpose of the present invention is achieved through the following technical solutions:

[0007] A nutritional composition for targeting PGC1β gene to enhance mitochondria of largemouth bass comprises the following components in parts by weight: 1-35 parts of dandelion flavonoids; 5-40 parts of baicalin; 5-35 parts of toosendanin; and 390-489 parts of expanded pearlite.

[0008] Preferably, the nutritional composition comprises the following components in parts by weight: 5-20 parts of dandelion flavonoids; 10-30 parts of baicalin; 10-30 parts of toosendanin; and 400-460 parts of expanded perlite.

[0009] More preferably, the nutritional composition comprises the following components in parts by weight: 10-15 parts of dandelion flavonoids; 20-25 parts of baicalin; 20-35 parts of toosendanin; and 420-440 parts of expanded perlite.

[0010] Preferably, the particle size of the expanded perlite is 3 to 7 mm.

[0011] The method for preparing the nutritional composition comprises the following steps: pulverizing dandelion flavonoids, baicalin, toosendanin and expanded perlite respectively in advance, passing through a sieve of 80-150 meshes, and then mixing them uniformly to obtain the nutritional composition.

[0012] Preferably, the temperature of the dandelion flavonoids, baicalin and toosendanin during pulverization is less than 40°C.

[0013] The nutritional composition is used in largemouth bass breeding, and the amount of the nutritional composition added to largemouth bass feed is 0.2-1.2wt%.

[0014] Compared with the prior art, the present invention has the following beneficial effects:

[0015] 1. The composition of the present invention uses dandelion flavonoids, baicalin and toosendanin as raw materials, fully utilizes the different characteristics of their biological structures for scientific compatibility, and exerts a synergistic effect to enhance the mitochondrial function of largemouth bass.

[0016] 2. The raw materials of the composition of the present invention, namely dandelion flavonoids, baicalin and toosendanin, are all components of medicinal plants, which can avoid food safety problems such as drug residues in aquatic products.

[0017] 3. The present invention selects PGC1β as the target, and by promoting the expression of PGC1β, enhances the biosynthesis capacity of mitochondria in largemouth bass, improves the energy metabolism function of the fish, and thus improves its feed utilization rate and breeding economic benefits, and can be applied in the field of largemouth bass breeding. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 The effects of different treatments on the expression of PGC1β in hepatocytes of largemouth bass;

[0019] Figure 2 Effects of different treatments on the number of mitochondria in hepatocytes of largemouth bass. DETAILED DESCRIPTION

[0020] The content of the present invention is further described below in conjunction with specific examples, but it should not be construed as limiting the present invention. If not specifically indicated, the technical means used in the examples are conventional means well known to those skilled in the art. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0021] The dandelion flavonoids, baicalin and toosendanin used in the examples of the present invention were purchased from Xi'an Youshuo Biotechnology Co., Ltd.

[0022] Example 1

[0023] According to the step-by-step mixing method, 1 part of dandelion flavonoids, 5 parts of baicalin, 5 parts of toosendanin and 489 parts of expanded perlite (particle size of 7 mm) which were crushed at 40°C and passed through an 80-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0024] Example 2

[0025] According to the step-by-step mixing method, 5 parts of dandelion flavonoids, 9 parts of baicalin, 11 parts of toosendanin and 475 parts of expanded perlite (particle size of 7 mm) which were crushed at 40°C and passed through an 80-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0026] Example 3

[0027] According to the step-by-step mixing method, 8 parts of dandelion flavonoids, 15 parts of baicalin, 15 parts of toosendanin and 462 parts of expanded perlite (particle size of 7 mm) which were crushed at 38° C. and passed through a 100-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0028] Example 4

[0029] According to the step-by-step mixing method, 15 parts of dandelion flavonoids, 18 parts of baicalin, 20 parts of toosendanin and 447 parts of expanded perlite (particle size of 7 mm) which were crushed at 38° C. and passed through a 100-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0030] Example 5

[0031] According to the step-by-step mixing method, 20 parts of dandelion flavonoids, 20 parts of baicalin, 25 parts of toosendanin and 435 parts of expanded perlite (particle size of 5 mm) which were crushed at 35° C. and passed through a 100-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0032] Example 6

[0033] According to the step-by-step mixing method, 22 parts of dandelion flavonoids, 25 parts of baicalin, 28 parts of toosendanin and 425 parts of expanded perlite (particle size of 5 mm) which were crushed at 35° C. and sieved through 120 mesh were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0034] Example 7

[0035] According to the step-by-step mixing method, 25 parts of dandelion flavonoids, 28 parts of baicalin, 28 parts of toosendanin and 419 parts of expanded perlite (particle size of 3 mm) which were crushed at 35° C. and passed through a 120-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0036] Example 8

[0037] According to the step-by-step mixing method, 27 parts of dandelion flavonoids, 30 parts of baicalin, 30 parts of toosendanin and 413 parts of expanded perlite (particle size of 3 mm) which were crushed at 35°C and passed through a 150-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0038] Example 9

[0039] According to the step-by-step mixing method, 30 parts of dandelion flavonoids, 35 parts of baicalin, 35 parts of toosendanin and 400 parts of expanded perlite (particle size of 3 mm) which were crushed at 30°C and passed through a 150-mesh sieve were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0040] Example 10

[0041] According to the step-by-step mixing method, 35 parts of dandelion flavonoids, 40 parts of baicalin, 35 parts of toosendanin and 390 parts of expanded perlite (particle size of 3 mm) which were crushed at 30° C. and sieved through 150 mesh were fully mixed. This process required that the mixture be uniform and stable to obtain a nutritional composition.

[0042] Application Example 1

[0043] In order to verify the effect of PGC1β gene expression on the number of mitochondria in largemouth bass hepatocytes, largemouth bass primary hepatocytes were cultured to 1.5×10 6cFU / mL, and then transferred to a 6-well cell culture plate and cultured for 24 hours, and then divided into ① blank control group: using culture medium (the glucose concentration in the culture medium is 5mmol / L, purchased from Gibco's DMEM / F12, model 11320033); ② PGC1β expression inhibition experimental group: PGC1β inhibition expression recombinant plasmid was transfected into largemouth bass primary hepatocytes and then added to the culture medium used in the blank control group. After culturing for 24 hours, the expression of PGC1β was determined by quantitative PCR technology, and the number of mitochondria in hepatocytes was detected by fluorescent staining using Mitotracker Red (also known as CMXros reagent). The results are shown in Figure 1 and 2 shown.

[0044] Figure 1 The effects of different treatment groups on the expression of PGC1β gene in hepatocytes of largemouth bass. Figure 1 It can be seen that the expression level of PGC1β gene in fish liver cells in the PGC1β inhibition experimental group was significantly lower than that in the blank control group. Figure 2 is the number of mitochondria in liver cells of largemouth bass in different treatment groups. Figure 2 It can be seen that the number of mitochondria in the liver cells of the fish in the experimental group with inhibition of PGC1β was significantly lower than that in the blank control group. This indicates that PGC1β is involved in the synthesis of mitochondria in the liver cells of largemouth bass, and inhibition of PGC1β will reduce the number of mitochondria in the liver cells of largemouth bass.

[0045] Application Example 2

[0046] Largemouth bass fry (about 10g) breeding experiment and result analysis: 600 fry of neat size (initial weight: 10.02±0.03g) were randomly placed in 20 cages (specifications: 2.0m×1.0m×1.0m), 30 fish in each cage, and cultured for 12 weeks. During this period, the feeding and growth conditions of the fry were observed. The feed formula is shown in Table 1. The ingredients of the basic feed are 40wt% fish meal, 26wt% soybean meal, 5wt% fish oil, 5wt% soybean oil, 20wt% corn starch, 2wt% monocalcium phosphate, and 2wt% premix. (1) Basic + dandelion flavonoids group: fed with basic feed supplemented with 1wt% dandelion flavonoids; (2) Basic + baicalin group: fed with basic feed supplemented with 1wt% baicalin; (3) Basic + toosendanin group: fed with basic feed supplemented with 1wt% toosendanin; (4) Basic + Composition 1 group: fed with basic feed supplemented with 1wt% of the nutritional composition of Example 1; (5) Basic + Composition 2 group: fed with basic feed supplemented with 1wt% of the nutritional composition of Example 2. After the end of the breeding, tissue samples were collected for subsequent index analysis. Table 2 shows the effects of feeds of different treatment groups on the growth, physiological and biochemical indicators of largemouth bass. As can be seen from Table 2, the basic + composition 2 group significantly increased the weight gain rate, PGC1β gene expression, Mitofusin-1 gene expression, mitochondrial enzyme complex I activity and mitochondrial enzyme complex II activity of largemouth bass. This shows that the basic + composition 2 group is superior in promoting fish growth, increasing mitochondrial synthesis and mitochondrial function.

[0047] Table 1 Feed formula for different treatment groups

[0048]

[0049] Premix: Each kg of premix contains the following minerals (g / kg) and vitamins (IU or mg / kg): CuSO4·5H2O, 2.0g; FeSO4·7H2O, 25g; ZnSO4·7H2O, 22g; MnSO4·4H2O, 7g; Na2SeO3, 0.04g; KI, 0.026g; CoCl2·6H2O, 0.1g; VA, 900,000IU; VD, 200,000IU; VE, 4500mg; VK3, 220mg; VB1, 320mg; VB2, 1090mg; niacin 2800mg; VB5, 2000mg; VB6, 500mg; VB12, 1.6mg; VC, 5000mg; pantothenic acid, 1000mg; folic acid, 165mg; choline, 60000mg; inositol, 15000mg.

[0050] Table 2 Effects of different treatment groups of feed on growth and physiological and biochemical parameters of largemouth bass

[0051]

[0052] Note: The same lowercase letters in the same row indicate no significant difference

[0053] Application Example 3

[0054] A breeding experiment on juvenile largemouth bass (about 23g) and result analysis: 600 juveniles of uniform size (initial weight: 23.41±0.12g) were randomly placed in 20 cages (specifications: 2.0m×1.0m×1.0m), with 30 fish in each cage. The culture was carried out for 12 weeks, during which the feeding and growth conditions of the juveniles were observed. The ingredients of the basic feed were 40wt% fish meal, 26wt% soybean meal, 5wt% fish oil, 5wt% soybean oil, 20wt% corn starch, 2wt% monocalcium phosphate, and 2wt% premix. (1) Basic + Composition 2 Group: fed with 1 wt% of the composition of Example 2 in the basic feed; (2) Basic + Composition 3 Group: fed with 1 wt% of the composition of Example 3 in the basic feed; (3) Basic + Composition 4 Group: fed with 1 wt% of the composition of Example 4 in the basic feed; (4) Basic + Composition 5 Group: fed with 1 wt% of the composition of Example 5 in the basic feed; (5) Basic + Composition 6 Group: fed with 1 wt% of the composition of Example 6 in the basic feed. After the breeding, tissue samples were collected for subsequent index analysis. Table 3 shows the effects of feeds of different treatment groups on the growth, physiological and biochemical indicators of largemouth bass. As can be seen from Table 3, the basic + composition 6 group significantly increased the weight gain rate, PGC1β gene expression, Mitofusin-1 gene expression, mitochondrial enzyme complex I activity and mitochondrial enzyme complex II activity of largemouth bass. This shows that the basic + composition 6 group is superior in promoting fish growth, increasing mitochondrial synthesis and mitochondrial function.

[0055] Table 3 Effects of different treatment groups of feed on growth and physiological and biochemical parameters of largemouth bass

[0056]

[0057] Note: The same lowercase letters in the same row indicate no significant difference

[0058] Application Example 4

[0059] Largemouth bass fry (about 58g) breeding experiment and result analysis: 360 fry of uniform size (initial weight: 58.44±0.14g) were randomly placed in 12 cages (specifications: 2.0m×1.0m×1.0m), 30 fish in each cage, and cultured for 12 weeks. During this period, the feeding and growth of the fry were observed. The ingredients of the basic feed were 40wt% fish meal, 26wt% soybean meal, 5wt% fish oil, 5wt% soybean oil, 20wt% corn starch, 2wt% calcium dihydrogen phosphate, and 2wt% premix. (1) Basic + Composition 6 Group: fed with 1wt% of the composition of Example 6 added to the basic feed; (2) Basic + Composition 8 Group: fed with 1wt% of the composition of Example 8 added to the basic feed; (3) Basic + Composition 10 Group: fed with 1wt% of the composition of Example 10 added to the basic feed. After the breeding, tissue samples were collected for subsequent index analysis. Table 4 shows the effects of feeds in different treatment groups on the growth, physiological and biochemical indicators of largemouth bass. As shown in Table 4, the basic + composite group 10 significantly increased the weight gain rate, PGC1β gene expression, Mitofusin-1 gene expression, mitochondrial enzyme complex I activity and mitochondrial enzyme complex II activity of largemouth bass. This shows that the basic + composite group 10 is better in promoting fish growth, increasing mitochondrial synthesis and mitochondrial function.

[0060] Table 4 Effects of different treatment groups’ diets on growth and physiological and biochemical parameters of largemouth bass

[0061]

[0062] Note: The same lowercase letters in the same row indicate no significant difference

[0063] The present invention combines the growth and physicochemical index results of relevant breeding experiments, confirms that the nutritional composition can enhance the mitochondrial biosynthesis capacity of fish and improve the mitochondrial function of fish by up-regulating the expression of PGC1β, and has a strong specificity for enhancing the mitochondrial biosynthesis capacity and mitochondrial function of largemouth bass liver, thereby improving the utilization efficiency of fish for feed.

[0064] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A nutritional composition for targeting PGC1β gene to enhance mitochondria of largemouth bass, characterized in that: The nutritional composition comprises the following components in parts by weight: 1 to 35 parts of dandelion flavonoids; 5 to 40 parts of baicalin; 5 to 35 parts of toosendanin; and 390 to 489 parts of expanded perlite.

2. The nutritional composition according to claim 1, characterized in that The nutritional composition comprises the following components in parts by weight: 5-20 parts of dandelion flavonoids; 10-30 parts of baicalin; 10-30 parts of toosendanin; and 400-460 parts of expanded pearlite.

3. The nutritional composition according to claim 2, characterized in that The nutritional composition comprises the following components in parts by weight: 10-15 parts of dandelion flavonoids; 20-25 parts of baicalin; 20-35 parts of toosendanin; and 420-440 parts of expanded perlite.

4. The nutritional composition according to any one of claims 1 to 3, characterized in that The particle size of the expanded perlite is 3 to 7 mm.

5. The method for preparing the nutritional composition according to any one of claims 1 to 4, characterized in that: The dandelion flavonoids, baicalin, toosendanin and expanded perlite are respectively crushed in advance, passed through a 80-150 mesh sieve, and then mixed evenly to obtain the product.

6. The method for preparing the nutritional composition according to claim 5, characterized in that: The temperatures of the dandelion flavonoids, baicalin and toosendanin when they are crushed are all lower than 40°C.

7. Use of the nutritional composition according to any one of claims 1 to 4 in largemouth bass breeding, characterized in that: The nutritional composition is added in the feed of largemouth bass in an amount of 0.2-1.2 wt %.